Johnson & Johnson vaccine is the third vaccine in Kenya’s program, with AstraZeneca and Moderna vaccines already in use.
During the arrival of the consignment at Jomo Kenyatta International Airport (JKIA), Health Chief Administrative Secretary, Dr. Mercy Mwangangi, said the arrival of the vaccine doses will help boost the ongoing vaccination drive, which aims to reach 10 million adult Kenyans by the end of the year.
According to Dr. Mwangangi, the single shot vaccine is expected to be very useful, especially when it reaches the primary healthcare level of the country’s health system, where vaccine uptake remains low.
In order to reach as many people as possible, the country will continue to use targeted approaches as well as a hybrid approach when it comes to outreach programmes.
By the end of the day, 2,809,389 vaccinations had been administered in the country, with 2,020,009 being first doses and 809,380 being fully vaccinated, representing 2.97 percent of the adult population.
As the number of people vaccinated against Covid-19 continues to rise, the Ministry of Health is confident that the curve will flatten out in the next three weeks.
Although the number of positive cases has decreased in recent weeks, the demand for oxygen remains high, according to the ministry.
As the virus mutated, the government issued an alert, raising concerns among health experts about the outbreak of a new variant in Latin America and the United Kingdom.
As per Dr. Patrick Amoth, acting director-general for health, there has been a significant decrease in the number of people testing positive for Covid-19.
He credited this to ongoing vaccination campaigns as well as a push to adhere to health regulations.
As the number of people vaccinated against Covid-19 continues to climb, the Ministry of Health is hopeful that the curve will level out in the next three weeks.
Although the number of positive cases has decreased in recent weeks, the need for oxygen remains strong, according to the ministry.
As the virus changed, the government issued an alert, increasing concerns among health experts about the breakout of a new variety in Latin America and the United Kingdom.
According to Dr. Patrick Amoth, interim director-general for health, the number of people testing positive for Covid-19 has dropped dramatically.